409 related articles for article (PubMed ID: 30698852)
21. Hijacking Chemical Reactions of P450 Enzymes for Altered Chemical Reactions and Asymmetric Synthesis.
Rajakumara E; Saniya D; Bajaj P; Rajeshwari R; Giri J; Davari MD
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613657
[TBL] [Abstract][Full Text] [Related]
22. P450 fingerprinting method for rapid discovery of terpene hydroxylating P450 catalysts with diversified regioselectivity.
Zhang K; El Damaty S; Fasan R
J Am Chem Soc; 2011 Mar; 133(10):3242-5. PubMed ID: 21341707
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 monooxygenases: perspectives for synthetic application.
Urlacher VB; Eiben S
Trends Biotechnol; 2006 Jul; 24(7):324-30. PubMed ID: 16759725
[TBL] [Abstract][Full Text] [Related]
24. Development of an improved Amplex Red peroxidation activity assay for screening cytochrome P450 variants and identification of a novel mutant of the thermophilic CYP119.
Başlar MS; Sakallı T; Güralp G; Kestevur Doğru E; Haklı E; Surmeli NB
J Biol Inorg Chem; 2020 Oct; 25(7):949-962. PubMed ID: 32924072
[TBL] [Abstract][Full Text] [Related]
25. Simulation-Guided Design of Cytochrome P450 for Chemo- and Regioselective Macrocyclic Oxidation.
Petrović D; Bokel A; Allan M; Urlacher VB; Strodel B
J Chem Inf Model; 2018 Apr; 58(4):848-858. PubMed ID: 29522682
[TBL] [Abstract][Full Text] [Related]
26. Emerging Strategies for Modifying Cytochrome P450 Monooxygenases into Peroxizymes.
Fan S; Cong Z
Acc Chem Res; 2024 Jan; ():. PubMed ID: 38293787
[TBL] [Abstract][Full Text] [Related]
27. The evolution of cytochrome P450 enzymes as biocatalysts in drug discovery and development.
Gillam EM; Hayes MA
Curr Top Med Chem; 2013; 13(18):2254-80. PubMed ID: 24047135
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic Study of the Stereoselective Hydroxylation of [2-
Yang CL; Lin CH; Luo WI; Lee TL; Ramu R; Ng KY; Tsai YF; Wei GT; Yu SS
Chemistry; 2017 Feb; 23(11):2571-2582. PubMed ID: 27798822
[TBL] [Abstract][Full Text] [Related]
29. An integrated screening system for the selection of exemplary substrates for natural and engineered cytochrome P450s.
Kanoh N; Kawamata-Asano A; Suzuki K; Takahashi Y; Miyazawa T; Nakamura T; Moriya T; Hirano H; Osada H; Iwabuchi Y; Takahashi S
Sci Rep; 2019 Dec; 9(1):18023. PubMed ID: 31792277
[TBL] [Abstract][Full Text] [Related]
30. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology.
Girvan HM; Munro AW
Curr Opin Chem Biol; 2016 Apr; 31():136-45. PubMed ID: 27015292
[TBL] [Abstract][Full Text] [Related]
31. Cluster screening: an effective approach for probing the substrate space of uncharacterized cytochrome P450s.
von Bühler C; Le-Huu P; Urlacher VB
Chembiochem; 2013 Nov; 14(16):2189-98. PubMed ID: 24115388
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450: taming a wild type enzyme.
Jung ST; Lauchli R; Arnold FH
Curr Opin Biotechnol; 2011 Dec; 22(6):809-17. PubMed ID: 21411308
[TBL] [Abstract][Full Text] [Related]
33. Substrate binding to cytochromes P450.
Isin EM; Guengerich FP
Anal Bioanal Chem; 2008 Nov; 392(6):1019-30. PubMed ID: 18622598
[TBL] [Abstract][Full Text] [Related]
34. Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.
Gillam EM
Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):147-52. PubMed ID: 15743395
[TBL] [Abstract][Full Text] [Related]
35. Expanding P450 catalytic reaction space through evolution and engineering.
McIntosh JA; Farwell CC; Arnold FH
Curr Opin Chem Biol; 2014 Apr; 19():126-34. PubMed ID: 24658056
[TBL] [Abstract][Full Text] [Related]
36. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
37. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
38. Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s.
Gillam EM
Arch Biochem Biophys; 2007 Aug; 464(2):176-86. PubMed ID: 17537393
[TBL] [Abstract][Full Text] [Related]
39. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
Narasimhulu S
Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
[TBL] [Abstract][Full Text] [Related]
40. Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.
Kumar S
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):115-31. PubMed ID: 20064075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
